Sunshine Biopharma, Inc. (OTCMKTS:SBFM) The Bull Has Awoken
July 18, 2020
Sunshine Biopharma, Inc. (OTCMKTS:SBFM) is moving up in a hurry on heavy accumulation, breaking out over current levels and surging over a penny on massive volume. The stock is quickly attracting legions of shareholders who continue to bid SBFM higher.
It’s easy to get excited about SBFM here; the Company recently filed a patent application for a new coronavirus COVID-19 Treatment. Sunshine Biopharma’s patent application covers composition subject matter pertaining to small molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for viral replication. The small molecules covered by the patent application were computer modelled and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
Sunshine Biopharma, Inc. (OTCMKTS:SBFM) is a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications. Since inception, SBFM proprietary drug development activities have been focused on the development of a small molecule called Adva-27a for the treatment of aggressive forms of cancer. A Topoisomerase II inhibitor, Adva-27a has been shown to be effective at destroying Multidrug Resistant Cancer cells including Pancreatic Cancer cells, Breast Cancer cells, Small-Cell Lung Cancer cells and Uterine Sarcoma cells. Sunshine Biopharma is direct owner of all issued and pending worldwide patents pertaining to Adva-27a including U.S. Patents Number 8,236,935 and 10,272,065.
Microcapdaily has been covering SBFM for many years; on April 4, 2016 we covered the stock commenting “Sunshine Biopharma, Inc. (OTCMKTS:SBFM) is making an explosive move up on accelerating volume since reversing off $0.0121 lows last week. The stock does have a history of big moves running from well under $0.25 to highs over $1.25 in 2011.
https://microcapdaily.com/sunshine-biopharma-inc-otcmktssbfm-the-bull-has-awoken/126598/
What will Sunshine BioPharma stock being doing JULY 2021?
